Nemec Sarah sold BOLT
September 18, 2026 · Form 4 insider transaction
Nemec Sarah sold 4,077 shares of Bolt Biotherapeutics, Inc. at $3.24 per share, a transaction worth $13.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.